12,119 Shares in Colgate-Palmolive (NYSE:CL) Acquired by ABC Arbitrage SA

ABC Arbitrage SA bought a new stake in shares of Colgate-Palmolive (NYSE:CL - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 12,119 shares of the company's stock, valued at approximately $1,102,000.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. D Orazio & Associates Inc. increased its stake in shares of Colgate-Palmolive by 3.9% in the third quarter. D Orazio & Associates Inc. now owns 2,862 shares of the company's stock valued at $297,000 after purchasing an additional 108 shares during the period. Fiducient Advisors LLC raised its stake in Colgate-Palmolive by 5.2% during the 3rd quarter. Fiducient Advisors LLC now owns 2,231 shares of the company's stock valued at $232,000 after acquiring an additional 110 shares in the last quarter. Sequoia Financial Advisors LLC boosted its position in Colgate-Palmolive by 0.6% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 20,392 shares of the company's stock worth $2,117,000 after acquiring an additional 113 shares during the period. Waldron Private Wealth LLC grew its stake in shares of Colgate-Palmolive by 2.1% in the third quarter. Waldron Private Wealth LLC now owns 5,632 shares of the company's stock worth $585,000 after purchasing an additional 118 shares in the last quarter. Finally, Commonwealth Financial Services LLC raised its position in shares of Colgate-Palmolive by 4.5% during the 4th quarter. Commonwealth Financial Services LLC now owns 2,716 shares of the company's stock worth $247,000 after buying an additional 118 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company's stock.

Colgate-Palmolive Stock Performance

Colgate-Palmolive stock traded up $0.93 on Wednesday, hitting $87.32. The company's stock had a trading volume of 3,814,410 shares, compared to its average volume of 4,924,800. The company has a fifty day moving average price of $89.24 and a 200-day moving average price of $96.11. The firm has a market cap of $70.86 billion, a P/E ratio of 24.81, a price-to-earnings-growth ratio of 4.10 and a beta of 0.44. Colgate-Palmolive has a one year low of $83.70 and a one year high of $109.30. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40.

Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period last year, the firm earned $0.87 earnings per share. On average, equities analysts anticipate that Colgate-Palmolive will post 3.76 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st were issued a dividend of $0.50 per share. The ex-dividend date of this dividend was Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.29%. Colgate-Palmolive's payout ratio is presently 56.82%.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on CL shares. TD Cowen cut their price objective on Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating for the company in a research report on Wednesday, January 8th. Stifel Nicolaus cut their price objective on Colgate-Palmolive from $95.00 to $93.00 and set a "hold" rating for the company in a report on Monday, February 3rd. StockNews.com lowered Colgate-Palmolive from a "buy" rating to a "hold" rating in a research report on Thursday, January 9th. Raymond James reissued an "outperform" rating and issued a $105.00 price target (down previously from $110.00) on shares of Colgate-Palmolive in a research note on Monday, February 3rd. Finally, Royal Bank of Canada reissued a "sector perform" rating and issued a $101.00 target price on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of $101.16.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.